Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esomeprazole vs Lansoprazole in Barrett's Esophagus
NCT00352261Phase 4Completed
- Sponsor
- AstraZeneca
- Start
- Jan 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of esomeprazole in Barrett's esophagus (2 arms), sponsored by AstraZeneca. Primary endpoint: Percentage of time that intragastric pH is >4.0 over a 24 hr period steady state (Once Daily). Started Jan 2006; status: completed.
02
Drugs
esomeprazole
03
Conditions
Barrett's esophagus
Beyond the preview
Go deeper on NCT00352261.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00352261.